CA2345378A1 - Neuro-immunophillines pour radioprotection neuronale selective - Google Patents
Neuro-immunophillines pour radioprotection neuronale selective Download PDFInfo
- Publication number
- CA2345378A1 CA2345378A1 CA002345378A CA2345378A CA2345378A1 CA 2345378 A1 CA2345378 A1 CA 2345378A1 CA 002345378 A CA002345378 A CA 002345378A CA 2345378 A CA2345378 A CA 2345378A CA 2345378 A1 CA2345378 A1 CA 2345378A1
- Authority
- CA
- Canada
- Prior art keywords
- neuroimmunophilin
- radiation
- ionizing radiation
- neurons
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
L'invention concerne un procédé et des produits pharmaceutiques permettant de protéger sélectivement les neurones contre les dégâts provoqués par le rayonnement ionisant, indépendamment de la source d'irradiation. Ce procédé est particulièrement utile pour protéger sélectivement les neurones normaux, mais non les cellules cérébrales tumorales, contre les effets dommageables du rayonnement ionisant.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1998/020040 WO2000016794A1 (fr) | 1998-09-23 | 1998-09-23 | Neuro-immunophillines pour radioprotection neuronale selective |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2345378A1 true CA2345378A1 (fr) | 2000-03-30 |
Family
ID=22267931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002345378A Abandoned CA2345378A1 (fr) | 1998-09-23 | 1998-09-23 | Neuro-immunophillines pour radioprotection neuronale selective |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1115412A4 (fr) |
JP (1) | JP2002526453A (fr) |
CN (1) | CN1322136A (fr) |
AP (1) | AP2001002113A0 (fr) |
AU (1) | AU766095B2 (fr) |
BR (1) | BR9816047A (fr) |
CA (1) | CA2345378A1 (fr) |
HK (1) | HK1040617A1 (fr) |
IL (1) | IL142120A0 (fr) |
WO (1) | WO2000016794A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE314084T1 (de) * | 2000-10-31 | 2006-01-15 | Pharma Mar Sa | Kahalalid f formulierung |
WO2005103255A1 (fr) * | 2004-03-25 | 2005-11-03 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Recepteur formylpeptide (fpr) utilise en tant que cible pour une therapie anti-gliome malin |
CN112218683A (zh) * | 2018-05-30 | 2021-01-12 | 睿谱外科系统股份有限公司 | 靠近关键结构的辐射外科手术神经调节 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE520730C2 (sv) * | 1995-01-20 | 2003-08-19 | Eskil Elmer | Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel |
JP3089350B2 (ja) * | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | シクロフィリンロタマーゼ活性の阻害剤 |
-
1998
- 1998-09-23 IL IL14212098A patent/IL142120A0/xx unknown
- 1998-09-23 BR BR9816047-8A patent/BR9816047A/pt not_active Application Discontinuation
- 1998-09-23 WO PCT/US1998/020040 patent/WO2000016794A1/fr not_active Application Discontinuation
- 1998-09-23 CN CN98814297A patent/CN1322136A/zh active Pending
- 1998-09-23 JP JP2000573755A patent/JP2002526453A/ja active Pending
- 1998-09-23 AU AU95081/98A patent/AU766095B2/en not_active Ceased
- 1998-09-23 AP APAP/P/2001/002113A patent/AP2001002113A0/en unknown
- 1998-09-23 CA CA002345378A patent/CA2345378A1/fr not_active Abandoned
- 1998-09-23 EP EP98948530A patent/EP1115412A4/fr not_active Withdrawn
-
2002
- 2002-03-13 HK HK02101925.6A patent/HK1040617A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1040617A1 (zh) | 2002-06-21 |
BR9816047A (pt) | 2003-01-07 |
IL142120A0 (en) | 2002-03-10 |
AU9508198A (en) | 2000-04-10 |
JP2002526453A (ja) | 2002-08-20 |
AP2001002113A0 (en) | 2001-06-30 |
CN1322136A (zh) | 2001-11-14 |
AU766095B2 (en) | 2003-10-09 |
EP1115412A4 (fr) | 2004-12-15 |
EP1115412A1 (fr) | 2001-07-18 |
WO2000016794A1 (fr) | 2000-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP734A (en) | Method of treating a human with nervous insult with cyclosporin. | |
Kaku et al. | Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage | |
Abigerges et al. | Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea | |
CA2061270C (fr) | Methode et appareil pour traiter les blessures de reperfusion | |
McEwen et al. | Treatment of migraine with intramuscular chlorpromazine | |
US20040147433A1 (en) | Neuroimmunophilins for selective neuronal radioprotection | |
Honey et al. | Human neural graft function in rats treated with anti-interleukin II receptor antibody | |
AU766095B2 (en) | Neuroimmunophilins for selective neuronal radioprotection | |
Mishra et al. | Intravesical tacrolimus in treatment of intractable interstitial cystitis/bladder pain syndrome–A pilot study | |
JP2655694B2 (ja) | 自己免疫起源の脱髄性疾患、特に多発性硬化症を処置するための医薬組成物 | |
NZ510739A (en) | Neuroimmunophilins for selective neuronal radioprotection | |
RU2222343C2 (ru) | Нейроиммунофилины для селективной противолучевой защиты нейронов | |
MXPA01003029A (en) | Neuroimmunophilins for selective neuronal radioprotection | |
Stancioiu et al. | Post-stroke recovery of motor function with a new combination of medicines-A pilot study | |
Bojö et al. | Involvement of vasoactive intestinal polypeptide in gastric reflex relaxation | |
US20110301102A1 (en) | Compositions and methods for treating myelodysplastic syndrome | |
Israel et al. | Treatment of nausea and vomiting related to anti-cancerous multiple combination chemotherapy: results of two controlled studies | |
EP1091750B1 (fr) | Composition pharmaceutique cerebrospinale et vasculaire et procede de preparation de ladite composition | |
Clarke et al. | Confusion and paranoia associated with oral tocainide | |
US3885030A (en) | Medicine comprising lysine by-products | |
US7846901B2 (en) | Method for inhibiting or treating intestinal damage caused by radiotherapy or chemotherapy comprising administering substance-P | |
Lee et al. | High incidence of local venous reactions to esorubicin | |
Tripathi et al. | Vincristine-Potent Mitotic Inhibitor | |
WO2024102696A1 (fr) | Utilisations de liposomes multivésiculaires de bupivacaïne comme bloc du ganglion stellaire pour le traitement de troubles anxieux et de traumatismes crânio-cérébraux | |
RU2066190C1 (ru) | Способ восстановления объема циркулирующей крови |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |